Effect of Telemedicine on Outcomes in Pregnant Women With Type 1 Diabetes Mellitus
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 1 Diabetes
- Sponsor
- Ana Braescu
- Enrollment
- 5
- Primary Endpoint
- HbA1c, maternal glycemic control
- Status
- Terminated
- Last Updated
- 3 years ago
Overview
Brief Summary
Hypothesize that co-managing pregnant type 1 diabetics with telemedicine will have at least equivalent outcomes to those managed with standard care. Comparison of outcomes between pregnant type 1 diabetics being co-managed with telemedicine compared to those receiving conventional care will help identify unanswered clinical questions and areas for improvement in regard to standards of care for pregnant type 1 diabetics. The data generated from this analysis will help determine whether telemedicine can be an effective additional means of care for pregnant type 1 diabetic patients.
Detailed Description
Few studies have researched the use of telemedicine in the management of type 1 diabetes during pregnancy. These studies are additionally limited due to the number of patients as well as several secondary outcomes reported. Therefore, this study will enroll 100 participants to reach a power of 81.8% with HbA1c as a primary outcome and secondary outcomes related to diabetic management such as frequency of hypoglycemia, antenatal hospital stay (percentage requiring admission, length of stay), miscarriage, cesarean section rates, induction of labor, fetal birth weight, gestational age at birth or preterm birth (\<34 weeks, \<37 weeks), frequency of neonatal hypoglycemia, shoulder dystocia, neonatal death, major and minor anomalies, and neonatal intensive care admission.
Investigators
Ana Braescu
Research Coordinator
Pediatrix
Eligibility Criteria
Inclusion Criteria
- •type 1 diabetics who are at or less than 16 weeks in their pregnancy
- •18 years of age or more
- •Voluntary participation
Exclusion Criteria
- •\<18 years of age
- •Not Type I diabetic
Outcomes
Primary Outcomes
HbA1c, maternal glycemic control
Time Frame: first trimester in pregnancy through 6 weeks postpartum
maternal glycemic control during pregnancy as measured by HbA1c